AKORN INC FDA Approval ANDA 079197

ANDA 079197

AKORN INC

FDA Drug Application

Application #079197

Documents

Review2013-01-22

Application Sponsors

ANDA 079197AKORN INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;IV (INFUSION)EQ 40MG BASE/VIAL0PANTOPRAZOLE SODIUMPANTOPRAZOLE SODIUM

FDA Submissions

ORIG1AP2012-11-08
LABELING; LabelingSUPPL3AP2021-03-17STANDARD
LABELING; LabelingSUPPL4AP2021-03-17STANDARD
LABELING; LabelingSUPPL5AP2021-03-17STANDARD
LABELING; LabelingSUPPL6AP2021-03-17STANDARD

Submissions Property Types

ORIG1Null19
SUPPL3Null7
SUPPL4Null7
SUPPL5Null15
SUPPL6Null15

TE Codes

001PrescriptionAP

CDER Filings

AKORN INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 79197
            [companyName] => AKORN INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PANTOPRAZOLE SODIUM","activeIngredients":"PANTOPRAZOLE SODIUM","strength":"EQ 40MG BASE\/VIAL","dosageForm":"INJECTABLE;IV (INFUSION)","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PANTOPRAZOLE SODIUM","submission":"PANTOPRAZOLE SODIUM","actionType":"EQ 40MG BASE\/VIAL","submissionClassification":"INJECTABLE;IV (INFUSION)","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.